New Line
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- Undisclosed
Investors
- 2
About New Line
Founded in 2018 in Weifang, China, Shandong New Line BIO INC. focuses on developing products that combat antibiotic resistance in farming. The company has engaged in one deal, with the most recent occurring on July 27, 2026.Shandong New Line BIO INC. specializes in the research, development, production, and sale of innovative feed additives designed to reduce reliance on antibiotics in livestock and agriculture. The company's core product offerings revolve around bacteriophage-based solutions, effectively addressing the growing issue of antibiotic-resistant bacteria in animal husbandry and crop production. These products, developed in collaboration with leading agricultural and scientific institutions, aim to improve animal health and productivity while ensuring food safety. Primary end users include livestock farmers and agricultural producers seeking effective alternatives for disease management in farming operations. Shandong New Line BIO INC.Shandong New Line BIO INC. operates on a business-to-business model, engaging directly with agricultural producers and livestock companies for sales transactions. The company's revenue generation is facilitated through the sale of its specialized bacteriophage products, structured as bulk orders or long-term supply agreements. Clients typically place orders based on specific needs for animal health interventions, focusing on promoting animal welfare and reducing antibiotic usage. The financial transactions are structured to support large-scale production and distribution, with pricing mechanisms aligned with the volume of product purchased. The company aims to design and launch new products targeting specific market needs, with plans for geographic expansion into various overseas markets, enhancing their global footprint.
Who invested in New Line
2 investors across 1 round
See all investors in New Line
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 27, 2026
Amount
Undisclosed
Investors
Questions about New Line
Who invested in New Line?
New Line has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has New Line raised?
New Line has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did New Line last raise money?
New Line's most recent round on record is a Series A, in Jul 2026.
What does New Line do?
Founded in 2018 in Weifang, China, Shandong New Line BIO INC.
Where is New Line headquartered?
New Line is headquartered in Weifang, China.
Which VCs invest in companies like New Line?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back agribusiness companies at New Line's stage. Their profiles are linked below.
VCs backing agribusiness startups at Series A
Raising like New Line? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.